| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |